Importantly, TEMo-Exo, but not NEMo-Exo, exhibited the potential to induce tumor growth and enhanced the expression of the tumor proliferation marker Ki-67 in BC xenograft tumors (Fig. 6). Here, MKI67 is linked to neoplasm.